Kinshasa:The Democratic Republic of the Congo (DRC) has initiated a clinical trial for an Ebola vaccine as part of its ongoing efforts to control the spread of the disease and enhance its health response capabilities.

According to Wam, the trial aims to assess the safety and efficacy of the vaccine, identify target groups for vaccination, and monitor any potential side effects that may arise during the study.

Health experts have emphasized that the commencement of the trial does not imply that the vaccine has been approved for widespread use or that its efficacy has been definitively proven. The approval and efficacy determination will rely on the outcome of the study and the analysis of the collected data.

Meanwhile, health authorities in the DRC are actively monitoring Ebola cases, isolating infected individuals, tracing contacts, and raising health awareness. They are also ensuring that frontline workers are equipped with the necessary tools to prevent further transmission of the virus.